PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Psychoneuroendocrinology

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Psychoneuroendocrinology has 1 tracked paper indexed in Blossom (2014) from 5 authors, most often covering MDMA, across Interpersonal Functioning & Social Connectedness.

Published Papers

Open Accessindividual

Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans

This double-blind trial (n=14) compared the effects of MDMA (52.5-105 mg/70kg), intranasal oxytocin (20 IU or 40 IU), and placebo on plasma oxytocin concentrations. MDMA (105 mg/70kg only) increased plasma oxytocin levels to a mean peak of 83.7 pg/ml at approximately 90-120 min compared to a 48.0 pg/ml, 30-60 min increase after oxytocin administration.

Published
August 1, 2014
Journal
Psychoneuroendocrinology
Authors
Kirkpatrick, M. G., Francis, S. M., Lee, R., de Wit, H., Jacob, S.

Quick Facts

Papers Indexed
1
h-Index
210
Open Access
No
Publisher
Elsevier
Country
United Kingdom
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.